日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors

对患有 TRK 融合肉瘤及相关间叶肿瘤的儿科患者选择性停用拉罗替尼

Mascarenhas, Leo; DuBois, Steven G; Albert, Catherine M; Bielack, Stefan; Orbach, Daniel; Federman, Noah; Geoerger, Birgit; Nagasubramanian, Ramamoorthy; Zhang, Yizhou; Chisholm, Julia; Gallego Melcon, Soledad; Goto, Hiroaki; Morgenstern, Daniel A; Owens, Cormac; Pappo, Alberto S; Perreault, Sébastien; Schulte, Johannes H; Shukla, Neerav; Zwaan, Christian Michel; Neu, Natascha; Bernard-Gauthier, Vadim; De La Cuesta, Esther; van Tilburg, Cornelis M; Laetsch, Theodore W

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial

抗GD2单克隆抗体naxitamab联合GM-CSF治疗复发或难治性高危神经母细胞瘤:一项II期临床试验

Mora, Jaume; Chan, Godfrey C F; Morgenstern, Daniel A; Amoroso, Loredana; Nysom, Karsten; Faber, Jörg; Wingerter, Arthur; Bear, Melissa K; Rubio-San-Simon, Alba; de Las Heras, Blanca Martínez; Tornøe, Karen; Düring, Maria; Kushner, Brian H

Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.

针对儿童肉瘤的 Mucin 16 靶向治疗:Ubamatamab 在上皮样肉瘤中的疗效病例证据及其对其他肉瘤亚型的意义

Connolly Denise M, Revon-Rivière Gabriel, Chami Rose, Mills Denise, Coblentz Ailish C, Uldrick Thomas S, Knorr David A, Goncalves Priscila, Dobosz Michael, Jalal Sumreen, Cohen-Gogo Sarah, Morgenstern Daniel A

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors

乐伐替尼联合依维莫司治疗复发性和难治性儿童及青少年实体瘤的1/2期研究

Dela Cruz, Filemon S; Fox, Elizabeth; DuBois, Steven G; Friedman, Gregory K; Croop, James M; Kim, AeRang; Morgenstern, Daniel A; Balis, Frank M; Macy, Margaret E; Pressey, Joseph G; Watt, Tanya; Krystal, Julie I; Vo, Kieuhoa T; Mody, Rajen; Laetsch, Theodore W; Weigel, Brenda J; O'Hara, Karen; He, Cixin S; Aluri, Jagadeesh; Okpara, Chinyere E; Glade Bender, Julia L

Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial

乐伐替尼联合异环磷酰胺和依托泊苷治疗复发性骨肉瘤儿童和青少年:一项 II 期随机临床试验

Gaspar, Nathalie; Hung, Giun-Yi; Strauss, Sandra J; Campbell-Hewson, Quentin; Dela Cruz, Filemon S; Glade Bender, Julia L; Koh, Kyung-Nam; Whittle, Sarah B; Chan, Godfrey Chi-Fung; Gerber, Nicolas U; Palmu, Sauli; Morgenstern, Daniel A; Longhi, Alessandra; Baecklund, Fredrik; Lee, Jun Ah; Locatelli, Franco; Márquez Vega, Catalina; Janeway, Katherine A; McCowage, Geoffrey; McCabe, Martin G; Bidadi, Behzad; Huang, Jie; McKenzie, Jodi; Okpara, Chinyere E; Bautista, Francisco

Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada

加拿大全国范围内儿童肿瘤创新疗法的可及性:加拿大全国经验报告

Judd, Sandra; Revon-Riviere, Gabriel; Grover, Stephanie A; Deyell, Rebecca J; Vanan, Magimairajan Issai; Lewis, Victor A; Pecheux, Lucie; Zorzi, Alexandra P; Goudie, Catherine; Santiago, Raoul; Tran, Thai Hoa; Abbott, Lesleigh S; Brossard, Josee; Moorehead, Paul; Alvi, Saima; Portwine, Carol; Denburg, Avram; Whitlock, James A; Cohen-Gogo, Sarah; Morgenstern, Daniel A

Characterisation of Paediatric Neuroblastic Tumours by Quantitative Structural and Diffusion-Weighted MRI

利用定量结构和扩散加权磁共振成像技术对儿童神经母细胞瘤进行表征

Tambasco, Domenica; Zlotnik, Margalit; Joshi, Sayali; Moineddin, Rahim; Harris, Shelley; Villani, Anita; Malkin, David; Morgenstern, Daniel A; Doria, Andrea S

Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

长期全身应用贝伐珠单抗治疗复发性呼吸道乳头状瘤病的肾脏影响

Robinson, Cal H; Hart-Matyas, Michael; Morgenstern, Daniel A; Noone, Damien; Campisi, Paolo

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

劳拉替尼联合或不联合化疗治疗ALK驱动的难治性/复发性神经母细胞瘤:1期临床试验结果

Goldsmith, Kelly C; Park, Julie R; Kayser, Kimberly; Malvar, Jemily; Chi, Yueh-Yun; Groshen, Susan G; Villablanca, Judith G; Krytska, Kateryna; Lai, Lillian M; Acharya, Patricia T; Goodarzian, Fariba; Pawel, Bruce; Shimada, Hiroyuki; Ghazarian, Susan; States, Lisa; Marshall, Lynley; Chesler, Louis; Granger, Meaghan; Desai, Ami V; Mody, Rajen; Morgenstern, Daniel A; Shusterman, Suzanne; Macy, Margaret E; Pinto, Navin; Schleiermacher, Gudrun; Vo, Kieuhoa; Thurm, Holger C; Chen, Joseph; Liyanage, Marlon; Peltz, Gerson; Matthay, Katherine K; Berko, Esther R; Maris, John M; Marachelian, Araz; Mossé, Yael P

The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations

整合基因组学在儿童癌症中的临床应用不仅限于可靶向突变。

Villani, Anita; Davidson, Scott; Kanwar, Nisha; Lo, Winnie W; Li, Yisu; Cohen-Gogo, Sarah; Fuligni, Fabio; Edward, Lisa-Monique; Light, Nicholas; Layeghifard, Mehdi; Harripaul, Ricardo; Waldman, Larissa; Gallinger, Bailey; Comitani, Federico; Brunga, Ledia; Hayes, Reid; Anderson, Nathaniel D; Ramani, Arun K; Yuki, Kyoko E; Blay, Sasha; Johnstone, Brittney; Inglese, Cara; Hammad, Rawan; Goudie, Catherine; Shuen, Andrew; Wasserman, Jonathan D; Venier, Rosemarie E; Eliou, Marianne; Lorenti, Miranda; Ryan, Carol Ann; Braga, Michael; Gloven-Brown, Meagan; Han, Jianan; Montero, Maria; Spatare, Famida; Whitlock, James A; Scherer, Stephen W; Chun, Kathy; Somerville, Martin J; Hawkins, Cynthia; Abdelhaleem, Mohamed; Ramaswamy, Vijay; Somers, Gino R; Kyriakopoulou, Lianna; Hitzler, Johann; Shago, Mary; Morgenstern, Daniel A; Tabori, Uri; Meyn, Stephen; Irwin, Meredith S; Malkin, David; Shlien, Adam